Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Seattle Genetics Inc (NASDAQ:SGEN)

52.29
BATS BZX Real-Time Price
As of 1:26pm ET
 +1.33 / +2.62%
Today’s Change
45.31
Today|||52-Week Range
71.32
-2.27%
Year-to-Date

Today’s Trading

Previous close50.95
Today’s open51.33
Day’s range50.91 - 52.67
Volume48,093
Average volume (3 months)989,885
Market cap$7.5B
Data as of 1:26pm ET, 01/17/2018

Growth & Valuation

Earnings growth (last year)-7.53%
Earnings growth (this year)+7.94%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+24.15%
P/E ratioNM
Price/Sales17.76
Price/Book11.74

Competitors

 Today’s
change
Today’s
% change
ALKSAlkermes Plc-0.44-0.78%
ALNYAlnylam Pharmaceutic...+0.61+0.49%
TSROTESARO Inc-3.01-4.59%
IONSIonis Pharmaceutical...+0.55+1.08%
Data as of 1:27pm ET, 01/17/2018

Financials

Next reporting dateFebruary 13, 2018
EPS forecast (this quarter)-$0.45
Annual revenue (last year)$418.1M
Annual profit (last year)-$140.1M
Net profit margin-33.51%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Financial Officer
Todd E. Simpson
Corporate headquarters
Bothell, Washington

Forecasts